Authors:
FISCHER T
NEUBAUER A
MOHM J
HUHN D
BUSEMANN C
LINK H
ARSENIEV L
BUSSING B
NOVOTNY J
GANSER A
DUYSTER J
BUNJES D
WESTERMEIER T
FLOHR T
DESPRES D
GAMM H
DECKER J
DERIGS G
AULITZKY W
HUBER C
Citation: T. Fischer et al., OUTCOME OF PERIPHERAL-BLOOD STEM-CELL MOBILIZATION IN ADVANCED PHASESOF CML IS DEPENDENT ON THE TYPE OF CHEMOTHERAPY APPLIED, Annals of hematology, 77(1-2), 1998, pp. 21-26
Authors:
HESS G
ROSE P
GAMM H
PAPADILERIS S
HUBER C
SELIGER B
Citation: G. Hess et al., MOLECULAR ANALYSIS OF THE ERYTHROPOIETIN RECEPTOR SYSTEM IN PATIENTS WITH POLYCYTHEMIA-VERA, British Journal of Haematology, 88(4), 1994, pp. 794-802
Authors:
CHAPEL H
DICATO M
GAMM H
BRENNAN V
RIES F
BUNCH C
LEE M
Citation: H. Chapel et al., IMMUNOGLOBULIN REPLACEMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - A COMPARISON OF 2 DOSE REGIMES, British Journal of Haematology, 88(1), 1994, pp. 209-212
Authors:
PEEST D
COLDEWEY R
DEICHER H
SAILER M
VYKOUPIL C
LEO R
GEORGII A
KAROW J
HOEPPNER E
DIEHL V
ESSERS U
GAMM H
GLUCK S
GORG K
GRAMATZKI M
HAUSWALDT C
HEILMANN E
HIEMEYER V
KEYSERLINGK HJ
KINDLER A
OERTEL J
PLANKER M
REINOLD HM
SCHAFER E
SCHUMACHER K
TIRIER C
URBANITZ D
SUCHY BR
WAHRISCH J
Citation: D. Peest et al., PROGNOSTIC VALUE OF CLINICAL, LABORATORY, AND HISTOLOGICAL CHARACTERISTICS IN MULTIPLE-MYELOMA - IMPROVED DEFINITION OF RISK GROUPS, European journal of cancer, 29A(7), 1993, pp. 978-983
Authors:
BORNEMANN A
BOHL J
HEY O
STORKEL S
GAMM H
MULLERFORELL W
PERNECZKY A
GOEBEL HH
Citation: A. Bornemann et al., AMYLOIDOMA OF THE GASSERIAN GANGLION AS A CAUSE OF SYMPTOMATIC NEURALGIA OF THE TRIGEMINAL NERVE - REPORT OF 3 CASES, Journal of neurology, 241(1), 1993, pp. 10-14
Authors:
SELIGER B
HESS G
GAMM H
ROSE P
PAPADILERIS S
HUBER C
Citation: B. Seliger et al., MOLECULAR ANALYSIS OF POLYCYTHEMIA-VERA WITH EMPHASIS OF THE ERYTHROPOIETIN RECEPTOR SYSTEM, Experimental hematology, 21(8), 1993, pp. 1070-1070